This report studies the follicle stimulating
hormone market.
Follicle stimulating hormone (FSH) is a
hormone made by the pituitary gland that affects the gonads (female ovaries and
males testes). In females, it stimulates growth of the ovarian follicles.
In this report, it refers to follicle
stimulating hormone drugs for human use. 1 dose is equal to 75 IU."
Scope
of the Report:
This report focuses on the Follicle
Stimulating Hormone in Global market, especially in North America, Europe and
Asia-Pacific, South America, Middle East and Africa. This report categorizes
the market based on manufacturers, regions, type and application.
Browse This Report: Global Follicle Stimulating Hormone Market by Manufacturers, Countries, Type and Application,Forecast to 2022
Market
Segment by Manufacturers, this report covers
- Merck Serono
- MSD
- IBSA
- Ferring
- Livzon
- Techwell
- GenSci
Market
Segment by Regions, regional analysis covers
- North America (USA, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Columbia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market
Segment by Type, covers
- Recombinant FSH
- Urinary FSH
Market
Segment by Applications, can be divided into
- Infertility Treatment
- Assisted Reproductive Technology
There
are 15 Chapters to deeply display the global Follicle Stimulating Hormone
market.
Chapter 1, to describe Follicle Stimulating
Hormone Introduction, product scope, market overview, market opportunities,
market risk, market driving force;
Chapter 2, to analyze the top manufacturers
of Follicle Stimulating Hormone, with sales, revenue, and price of Follicle
Stimulating Hormone, in 2016 and 2017;
Chapter 3, to display the competitive
situation among the top manufacturers, with sales, revenue and market share in
2016 and 2017;
Chapter 4, to show the global market by
regions, with sales, revenue and market share of Follicle Stimulating Hormone,
for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the
key regions, with sales, revenue and market share by key countries in these
regions;
Chapter 10 and 11, to show the market by
type and application, with sales market share and growth rate by type,
application, from 2012 to 2017;
Chapter 12, Follicle Stimulating Hormone
market forecast, by regions, type and application, with sales and revenue, from
2017 to 2022;
Chapter 13, 14 and 15, to describe Follicle
Stimulating Hormone sales channel, distributors, traders, dealers, Research
Findings and Conclusion, appendix and data source
Spanning over 115 pages “Global
Follicle Stimulating Hormone Market by Manufacturers, Countries, Type and
Application, Forecast to 2022” report covers Market Overview,
Manufacturers Profiles, Global Follicle Stimulating Hormone Market Competition,
by Manufacturer, Global Follicle Stimulating Hormone Market Analysis by Regions,
North America Follicle Stimulating Hormone by Countries, Europe Follicle
Stimulating Hormone by Countries, Asia-Pacific Follicle Stimulating Hormone by
Countries, South America Follicle Stimulating Hormone by Countries, Middle East
and Africa Follicle Stimulating Hormone by Countries, Global Follicle
Stimulating Hormone Market Segment by Type, Global Follicle Stimulating Hormone
Market Segment by Application, Follicle Stimulating Hormone Market Forecast
(2017-2022), Sales Channel, Distributors, Traders and Dealers, Research
Findings and Conclusion, Appendix.
Please visit this link for more details: http://mrr.cm/UBs
For related reports please visit: Stimulating Hormone Market Research Reports
Find all Pharma
and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.